Equities research analysts forecast that Proto Labs, Inc. (NYSE:PRLB) will post $85.53 million in sales for the current fiscal quarter, Zacks reports. Three analysts have issued estimates for Proto Labs’ earnings, with estimates ranging from $85.30 million to $85.99 million. Proto Labs reported sales of $78.17 million during the same quarter last year, which indicates a positive year-over-year growth rate of 9.4%. The firm is expected to report its next quarterly earnings report before the market opens on Thursday, October 26th.

According to Zacks, analysts expect that Proto Labs will report full-year sales of $85.53 million for the current financial year, with estimates ranging from $333.89 million to $336.70 million. For the next financial year, analysts expect that the company will report sales of $369.60 million per share, with estimates ranging from $366.39 million to $374.31 million. Zacks’ sales calculations are a mean average based on a survey of research firms that follow Proto Labs.

Proto Labs (NYSE:PRLB) last announced its quarterly earnings data on Thursday, July 27th. The industrial products company reported $0.49 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.43 by $0.06. Proto Labs had a return on equity of 11.75% and a net margin of 14.59%. The business had revenue of $82.04 million during the quarter, compared to analyst estimates of $80.49 million. During the same period last year, the company earned $0.45 earnings per share. Proto Labs’s quarterly revenue was up 9.4% compared to the same quarter last year.

PRLB has been the subject of a number of recent research reports. Piper Jaffray Companies restated a “hold” rating and set a $67.00 price objective on shares of Proto Labs in a research note on Friday, July 28th. Dougherty & Co upgraded shares of Proto Labs from a “sell” rating to a “neutral” rating in a research note on Tuesday, June 27th. Finally, BidaskClub downgraded shares of Proto Labs from a “strong-buy” rating to a “buy” rating in a research note on Friday. Three equities research analysts have rated the stock with a hold rating and one has assigned a buy rating to the stock. Proto Labs currently has a consensus rating of “Hold” and a consensus price target of $56.00.

In other news, VP Robert Bodor sold 741 shares of the stock in a transaction dated Thursday, July 27th. The shares were sold at an average price of $73.84, for a total transaction of $54,715.44. Following the completion of the transaction, the vice president now directly owns 17,319 shares in the company, valued at approximately $1,278,834.96. The transaction was disclosed in a document filed with the SEC, which is available at this link. Corporate insiders own 7.78% of the company’s stock.

Hedge funds have recently modified their holdings of the company. Victory Capital Management Inc. raised its holdings in shares of Proto Labs by 65.6% in the 1st quarter. Victory Capital Management Inc. now owns 1,974 shares of the industrial products company’s stock valued at $101,000 after purchasing an additional 782 shares during the period. Ameritas Investment Partners Inc. bought a new stake in shares of Proto Labs in the 1st quarter valued at about $109,000. UBS Group AG raised its holdings in shares of Proto Labs by 128.0% in the 1st quarter. UBS Group AG now owns 2,603 shares of the industrial products company’s stock valued at $133,000 after purchasing an additional 11,895 shares during the period. SG Americas Securities LLC raised its holdings in shares of Proto Labs by 27.1% in the 1st quarter. SG Americas Securities LLC now owns 2,830 shares of the industrial products company’s stock valued at $145,000 after purchasing an additional 603 shares during the period. Finally, Invictus RG bought a new stake in shares of Proto Labs in the 1st quarter valued at about $179,000.

ILLEGAL ACTIVITY WARNING: “Zacks: Analysts Anticipate Proto Labs, Inc. (PRLB) Will Post Quarterly Sales of $85.53 Million” was originally posted by Watch List News and is the sole property of of Watch List News. If you are reading this news story on another site, it was illegally copied and reposted in violation of United States and international copyright and trademark laws. The original version of this news story can be viewed at https://www.watchlistnews.com/zacks-analysts-anticipate-proto-labs-inc-prlb-will-post-quarterly-sales-of-85-53-million/1613421.html.

Proto Labs (NYSE PRLB) traded down 0.37% during trading on Tuesday, reaching $80.25. The company’s stock had a trading volume of 40,781 shares. The company’s 50 day moving average price is $74.11 and its 200 day moving average price is $65.65. Proto Labs has a 52 week low of $43.10 and a 52 week high of $82.50. The company has a market cap of $2.14 billion, a P/E ratio of 46.66 and a beta of 0.99.

About Proto Labs

Proto Labs, Inc is an e-commerce driven digital manufacturer of on-demand three dimensional (3D) printed, computer numerical control (CNC) machined and injection-molded custom parts for prototyping and short-run production. The Company’s geographic segments include the United States, Europe and Japan.

Get a free copy of the Zacks research report on Proto Labs (PRLB)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Proto Labs Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proto Labs Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.